学术探索
学术期刊
新闻热点
数据分析
智能评审

Drugs of the 21st century: telithromycin (HMR 3647) - the first ketolide

被引：92
作者：
Ackermann, G [1 ]
Rodloff, AC [1 ]
机构：
[1] Univ Leipzig, Inst Med Microbiol & Epidemiol Infect Dis, D-04103 Leipzig, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 03期
关键词：
new antimicrobials; telithromycin; resistance;
D O I：
10.1093/jac/dkg123
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Telithromycin (HMR 3647) is the first ketolide introduced into clinical practice. Ketolides are semisynthetic derivates of erythromycin A that carry novel biological properties on the erythronolide A ring. This new class of antimicrobials was designed to overcome current resistance mechanisms against erythromycin A within Gram-positive cocci. Ketolides do not induce macrolide-lincosamide-streptogramin B (MLSB) resistance and are active against erythromycin resistance methylase gene (erm)-carrying Gram-positive cocci. This review summarizes published data on telithromycin and intends to define the challenge that a new antimicrobial brings to medical practice.
引用
收藏
页码：497 / 511
页数：15
相关论文
共 104 条
  • [1] In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria
    Ackermann, G
    Schaumann, R
    Pless, B
    Claros, MC
    Rodloff, AC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (01) : 115 - 119
  • [2] AGOURIDAS C, 1998, 4 INT C MACR AZ STRE
  • [3] Resistance among Streptococcus pneumoniae:: Implications for drug selection
    Appelbaum, PC
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) : 1613 - 1620
  • [4] Use of ketolides in combination with other drugs to treat experimental toxoplasmosis
    Araujo, FG
    Khan, AA
    Bryskier, A
    Remington, JS
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) : 665 - 667
  • [5] AUBIER M, 2001, 41 INT C ANT AG CHEM, P450
  • [6] *AVENT PHARM, 2002, FACH KET 400 MG FILM
  • [7] The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution
    Ban, N
    Nissen, P
    Hansen, J
    Moore, PB
    Steitz, TA
    [J]. SCIENCE, 2000, 289 (5481) : 905 - 920
  • [8] Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)
    Barry, AL
    Fuchs, PC
    Brown, SD
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) : 945 - 946
  • [9] Interpretative criteria and duality control parameters for telithromycin disc diffusion susceptibility tests
    Barry, AL
    Fuchs, PC
    Brown, SD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (01) : 121 - 125
  • [10] Barry AL, 2001, EUR J CLIN MICROBIOL, V20, P494
12345678910